AUPR703601A0 - Identification and isolation of somatic stem cells and uses thereof - Google Patents

Identification and isolation of somatic stem cells and uses thereof

Info

Publication number
AUPR703601A0
AUPR703601A0 AUPR7036A AUPR703601A AUPR703601A0 AU PR703601 A0 AUPR703601 A0 AU PR703601A0 AU PR7036 A AUPR7036 A AU PR7036A AU PR703601 A AUPR703601 A AU PR703601A AU PR703601 A0 AUPR703601 A0 AU PR703601A0
Authority
AU
Australia
Prior art keywords
stem cells
isolation
identification
cell
somatic stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR7036A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peter MacCallum Cancer Institute
Original Assignee
Peter MacCallum Cancer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter MacCallum Cancer Institute filed Critical Peter MacCallum Cancer Institute
Priority to AUPR7036A priority Critical patent/AUPR703601A0/en
Publication of AUPR703601A0 publication Critical patent/AUPR703601A0/en
Priority to AU2002355970A priority patent/AU2002355970B2/en
Priority to ES02750673T priority patent/ES2381183T3/es
Priority to CA2457632A priority patent/CA2457632C/en
Priority to EP02750673A priority patent/EP1432991B1/en
Priority to AT02750673T priority patent/ATE543098T1/de
Priority to PCT/AU2002/001101 priority patent/WO2003016916A1/en
Priority to JP2003521372A priority patent/JP4922548B2/ja
Priority to IL16039402A priority patent/IL160394A0/xx
Priority to US10/486,845 priority patent/US7718376B2/en
Priority to IL160394A priority patent/IL160394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
AUPR7036A 2001-08-15 2001-08-15 Identification and isolation of somatic stem cells and uses thereof Abandoned AUPR703601A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AUPR7036A AUPR703601A0 (en) 2001-08-15 2001-08-15 Identification and isolation of somatic stem cells and uses thereof
US10/486,845 US7718376B2 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof
EP02750673A EP1432991B1 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof
ES02750673T ES2381183T3 (es) 2001-08-15 2002-08-15 Identificación y aislamiento de citoblastos somáticos y usos de los mismos
CA2457632A CA2457632C (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof
AU2002355970A AU2002355970B2 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof
AT02750673T ATE543098T1 (de) 2001-08-15 2002-08-15 Identifizierung und isolierung somatischer stammzellen und verwendungen davon
PCT/AU2002/001101 WO2003016916A1 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof
JP2003521372A JP4922548B2 (ja) 2001-08-15 2002-08-15 体性幹細胞の同定および単離ならびにその使用
IL16039402A IL160394A0 (en) 2001-08-15 2002-08-15 Methods for identifying and isolating stem cells and methods utilizing said cells
IL160394A IL160394A (en) 2001-08-15 2004-02-13 Methods for identifying and isolating stem cells and methods using these cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR7036A AUPR703601A0 (en) 2001-08-15 2001-08-15 Identification and isolation of somatic stem cells and uses thereof

Publications (1)

Publication Number Publication Date
AUPR703601A0 true AUPR703601A0 (en) 2001-09-06

Family

ID=3830992

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPR7036A Abandoned AUPR703601A0 (en) 2001-08-15 2001-08-15 Identification and isolation of somatic stem cells and uses thereof
AU2002355970A Ceased AU2002355970B2 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002355970A Ceased AU2002355970B2 (en) 2001-08-15 2002-08-15 Identification and isolation of somatic stem cells and uses thereof

Country Status (9)

Country Link
US (1) US7718376B2 (https=)
EP (1) EP1432991B1 (https=)
JP (1) JP4922548B2 (https=)
AT (1) ATE543098T1 (https=)
AU (2) AUPR703601A0 (https=)
CA (1) CA2457632C (https=)
ES (1) ES2381183T3 (https=)
IL (2) IL160394A0 (https=)
WO (1) WO2003016916A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
WO2004069172A2 (en) 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
CN100377165C (zh) * 2003-04-24 2008-03-26 皇家飞利浦电子股份有限公司 无创式左心室的容积测定
EP1656443A4 (en) * 2003-05-02 2007-06-06 Sigma Aldrich Co SOLID PHASE CELLYSIS AND IMPACT PLATFORM
RU2271818C1 (ru) * 2004-08-18 2006-03-20 ЗАО "РеМеТэкс" Биотрансплантат, способ его получения и способ лечения косметических дефектов кожи (варианты)
RU2271817C1 (ru) * 2004-08-18 2006-03-20 ЗАО "РеМеТэкс" Биотрансплантат и способ лечения легочной гипертензии
RU2271819C1 (ru) * 2004-08-18 2006-03-20 ЗАО "РеМеТэкс" Биотрансплантат, способ его получения (варианты) и способ лечения алопеции
RU2272638C1 (ru) * 2004-08-18 2006-03-27 ЗАО "РеМеТэкс" Биотрансплантат, способ его получения и способ лечения хронического гепатита и цирроза печени (варианты)
EP1870455A4 (en) * 2005-03-31 2010-01-20 Two Cells Co Ltd METHOD FOR DISTINCTION OF MESENCHYMAL STEM CELL USING MOLECULAR MARKER AND USE THEREOF
EP1976878A4 (en) * 2006-01-30 2010-06-02 Fred Hutchinson Cancer Res Fou FOLLOW OF THE VARIABLE STRO-1 ANTIBODY REGION
US20080025953A1 (en) * 2006-07-25 2008-01-31 Kiminobu Sugaya Vigor Enhancement of Animals Via Administration of Stem Cells
US9487756B2 (en) * 2009-03-20 2016-11-08 Mesoblast, Inc. Production of reprogrammed pluripotent cells
ES2609006T3 (es) * 2009-10-16 2017-04-18 Rutgers, The State University Of New Jersey Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
US9081008B2 (en) 2009-12-04 2015-07-14 James Sherley Detecting and counting tissue—specific stem cells and uses thereof
US8759098B2 (en) 2009-12-04 2014-06-24 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
WO2011069121A1 (en) * 2009-12-04 2011-06-09 Neostem, Inc. Mesenchymal stem cells (mscs) isolated from mobilized peripheral blood
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6017845B2 (ja) * 2011-06-10 2016-11-02 帝人ファーマ株式会社 Ｇｐｉアンカータンパク質欠損細胞の検出方法
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN105866432B (zh) * 2016-05-11 2018-01-26 天津欣普赛尔生物医药科技有限公司 用于鉴定牙髓间充质干细胞的试剂盒
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
FR3062213B1 (fr) * 2017-01-20 2021-02-26 Endodiag Utilisation du recepteur cd71 dans la detection et le traitement de l’endometriose
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582790A (en) 1983-02-15 1986-04-15 Wisconsin Alumni Research Foundation Monoclonal antibody to angiotension-converting enzyme and methods of preparing and using same
AU721129B2 (en) * 1996-01-08 2000-06-22 Genentech Inc. WSX receptor and ligands
WO1998021334A2 (en) 1996-11-13 1998-05-22 Morphogenesis, Inc. Antibody mg1 recognizing a small subset of human hematopoietic cells
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell

Also Published As

Publication number Publication date
EP1432991A1 (en) 2004-06-30
US7718376B2 (en) 2010-05-18
JP2004538490A (ja) 2004-12-24
ES2381183T3 (es) 2012-05-23
CA2457632C (en) 2014-07-15
ATE543098T1 (de) 2012-02-15
JP4922548B2 (ja) 2012-04-25
EP1432991B1 (en) 2012-01-25
IL160394A (en) 2011-07-31
WO2003016916A1 (en) 2003-02-27
IL160394A0 (en) 2004-07-25
US20060088890A1 (en) 2006-04-27
AU2002355970B2 (en) 2008-10-23
CA2457632A1 (en) 2003-02-27
EP1432991A4 (en) 2006-05-10

Similar Documents

Publication Publication Date Title
AUPR703601A0 (en) Identification and isolation of somatic stem cells and uses thereof
WO2002086498A8 (en) Systems and methods for automated analysis of cells and tissues
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
ATE414783T1 (de) Verfahren zur isolierung von stammzellen
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
AU2002348563A1 (en) Nucleic acid enrichment
CA2410888A1 (en) Nucleic acid isolation
WO2003076932A3 (de) Detektion und analyse von protein-interaktionen in vivo
GB9709728D0 (en) Single step method
WO2001090345A3 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
AU4040097A (en) Signal amplification method
WO2000075363A3 (en) Enzymatic measurement of mycophenolic acid
DK1404862T3 (da) Termostabile proteinaser fra termofile bakterier
WO2001077379A3 (en) A method of cell detection
NO994705L (no) Preparering av blodpröver for deteksjon av homocystein og/eller folat
AU2003296591A1 (en) Method for the identification of sulfo-reducing bacteria
WO2005029038A3 (en) Detection of potassium ions using ion-sensitive enzymes
AU2001289547A1 (en) Method for determining the age of individuals
AU2606800A (en) Methods of determining an increased risk of a woman carrying a downs syndrome
AU2002220797A1 (en) Method for identifying listeria monocytogenes and culture medium
WO2002033127A3 (en) Method for assessing recoding in vitro and in vivo
WO2002064756A3 (en) Stem cell identification
WO2002020835A3 (en) Genetic study
GB0206585D0 (en) Method
WO2000020629A3 (en) Quantitation of rna